PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist peptide. It's primarily known for its potential in research related to sexual dysfunction, but its broader effects on melanocortin receptors have opened up other avenues of investigation. This article provides a comprehensive overview of PT-141, focusing on its mechanism of action, research applications, quality markers, potential impurities, and proper storage to ensure reliable and reproducible results.

Molecular Structure and Properties

Bremelanotide is a cyclic heptapeptide with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Its molecular formula is C₅₀H₆₈N₁₄O₁₀, and its molecular weight is approximately 1025.2 Da. The cyclic structure is crucial for its receptor binding affinity and selectivity. The acetylation at the N-terminus (Ac-) and amidation at the C-terminus (-NH2) enhance stability and bioavailability.

Key Structural Features:

• Cyclic Structure: The cyclization is essential for proper receptor binding.
• Nle (Norleucine): A non-natural amino acid that improves metabolic stability.
• D-Phe (D-Phenylalanine): The D-isomer contributes to receptor selectivity.

Mechanism of Action

PT-141 exerts its effects by binding to melanocortin receptors (MCRs), specifically MC1R, MC3R, and MC4R. While it binds to multiple MCRs, its primary activity related to sexual function is attributed to its interaction with MC4R in the central nervous system. Activation of MC4R triggers a cascade of neuronal signaling events that influence sexual arousal and desire.

Unlike PDE5 inhibitors like sildenafil (Viagra), which act peripherally to increase blood flow to the genitals, PT-141 acts centrally, modulating brain activity related to sexual response. This difference in mechanism of action makes it a potential research tool for studying the neurological pathways involved in sexual dysfunction, particularly in cases where peripheral mechanisms are ineffective.

Receptor Binding Affinities (Approximate):

• MC1R: Ki ? 10 nM
• MC3R: Ki ? 3 nM
• MC4R: Ki ? 0.7 nM
• MC5R: Ki ? 100 nM

These binding affinities highlight the relatively high affinity of PT-141 for MC3R and MC4R, suggesting that its effects are likely mediated through these receptors.

Research Applications

The primary research focus of PT-141 is in the area of sexual dysfunction, but its broader melanocortin receptor activity has spurred investigation into other potential applications:

• Female Sexual Dysfunction (FSD): PT-141 has been investigated as a potential treatment for hypoactive sexual desire disorder (HSDD) in women. Research explores its ability to increase sexual desire and arousal through central nervous system mechanisms.
• Erectile Dysfunction (ED): While PDE5 inhibitors are the first-line treatment for ED, PT-141 offers a potential alternative, particularly for individuals who do not respond to or cannot tolerate PDE5 inhibitors. Studies explore its efficacy in treating ED through central nervous system pathways.
• Melanocortin Receptor Research: PT-141 serves as a valuable tool for studying the role of melanocortin receptors in various physiological processes, including energy homeostasis, inflammation, and immune function. Its receptor binding profile allows researchers to probe the specific contributions of different MCR subtypes.
• Pigmentation Research: MC1R plays a crucial role in melanogenesis. PT-141's affinity for MC1R makes it a potential tool for investigating pigmentation pathways and developing novel therapeutic strategies for skin disorders related to melanin production. However, its use in this area is limited due to the availability of more selective MC1R agonists.

Quality Markers and Assessment

Ensuring the quality of PT-141 is paramount for obtaining reliable and reproducible research results. Key quality markers include peptide purity, sequence identity, peptide content, water content, and counterion content. Here's a detailed breakdown:

1. Peptide Purity

Purity refers to the percentage of the peptide in the sample that is the desired sequence. High purity is essential to minimize the confounding effects of impurities. The industry standard for research-grade peptides is typically ?95% purity, although higher purities (e.g., ?98%) may be desirable for sensitive applications.

Analytical Methods for Purity Assessment:

• Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC): This is the most common method for determining peptide purity. The peptide is separated based on its hydrophobicity, and the area under the peak corresponding to the desired peptide is used to calculate the purity. A gradient elution with acetonitrile and water (containing trifluoroacetic acid, TFA) is typically used.
• Ultra-Performance Liquid Chromatography (UPLC): UPLC offers higher resolution and faster analysis times compared to HPLC. It can be particularly useful for separating closely related impurities.
• Capillary Electrophoresis (CE): CE is an alternative separation technique that can be used to assess peptide purity, especially for peptides with complex structures or those that are difficult to analyze by HPLC.

Practical Tip: When evaluating RP-HPLC data, pay attention to the presence of any significant impurity peaks. The purity reported by the supplier should be based on the integrated area of the main peak, excluding solvent peaks and baseline noise.

2. Sequence Identity

Sequence identity confirms that the peptide has the correct amino acid sequence. This is crucial for ensuring that the peptide will bind to the intended target receptor.

Analytical Methods for Sequence Identity Assessment:

• Mass Spectrometry (MS): MS is the gold standard for confirming sequence identity. The peptide is ionized, and its mass-to-charge ratio is measured. This information can be used to determine the amino acid sequence. Common MS techniques include MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) and ESI-MS (Electrospray Ionization Mass Spectrometry).
• Edman Degradation: This classical method involves sequentially removing and identifying amino acids from the N-terminus of the peptide. While less common than MS, it can be used to confirm the N-terminal sequence.

Practical Tip: Request mass spectrometry data from the supplier to verify the sequence identity. The observed mass should match the theoretical mass of PT-141 (1025.2 Da) within a reasonable tolerance (e.g., ± 1 Da).

3. Peptide Content

Peptide content refers to the actual amount of peptide present in the sample, taking into account factors such as water content, counterion content, and residual solvents. It is typically expressed as a percentage.

Analytical Methods for Peptide Content Assessment:

• Amino Acid Analysis (AAA): This method involves hydrolyzing the peptide into its constituent amino acids and quantifying the amount of each amino acid. The peptide content can then be calculated based on the amino acid composition.
• Quantitative UV Spectrophotometry: If the peptide contains a chromophore (e.g., tryptophan), its concentration can be determined by measuring its absorbance at a specific wavelength (e.g., 280 nm for tryptophan). A known extinction coefficient is required for this method.

Practical Tip: Peptide content is often lower than 100% due to the presence of water, counterions, and residual solvents. Request the peptide content value from the supplier and use it to accurately calculate the amount of peptide needed for your experiments.

4. Water Content

Water content can affect the stability and accurate weighing of the peptide. Excessive water content can lead to peptide degradation and inaccurate concentration calculations.

Analytical Methods for Water Content Assessment:

• Karl Fischer Titration: This is the most common method for determining water content. It involves a chemical reaction that selectively reacts with water, allowing for its quantification.

Practical Tip: The water content of lyophilized peptides is typically in the range of 5-10%. Request the water content value from the supplier and store the peptide under desiccating conditions to minimize water absorption.

5. Counterion Content

Peptides are often synthesized and purified as salts, with counterions such as trifluoroacetate (TFA) or acetate. The counterion content can affect the peptide's solubility and biological activity.

Analytical Methods for Counterion Content Assessment:

• Ion Chromatography (IC): This method can be used to quantify the amount of counterions present in the sample.
• Nuclear Magnetic Resonance (NMR) Spectroscopy: NMR can provide information about the structure and composition of the peptide, including the presence of counterions.

Practical Tip: TFA is a common counterion in peptide synthesis and purification. While it is generally well-tolerated in biological assays, it can sometimes interfere with cell culture experiments. If necessary, TFA can be removed by lyophilizing the peptide from a solution of ammonium acetate or hydrochloric acid.

Common Impurities

Peptide synthesis is not a perfect process, and several impurities can be present in the final product. Common impurities include:

• Deletion Peptides: Peptides that are missing one or more amino acids.
• Truncated Peptides: Peptides that are shorter than the desired sequence due to incomplete synthesis.
• Modified Peptides: Peptides that contain modified amino acids (e.g., oxidized methionine, deamidated asparagine).
• Diastereomers: Peptides that contain one or more amino acids in the wrong stereoisomeric form (e.g., L-amino acid instead of D-amino acid).
• Residual Solvents: Solvents used during synthesis and purification that may remain in the final product.

Table: Comparison of Quality Markers and Analytical Methods

Storage Requirements

Proper storage is crucial for maintaining the stability and integrity of PT-141. Follow these guidelines:

• Temperature: Store lyophilized PT-141 at -20°C or -80°C for long-term storage. Avoid repeated freeze-thaw cycles.
• Desiccation: Store the peptide in a tightly sealed container with a desiccant to minimize water absorption.
• Light Protection: Protect the peptide from light by storing it in a dark container or wrapping it in foil.
• Solution Stability: Once reconstituted in solution, PT-141 is less stable and should be used promptly or stored at -20°C or -80°C for short periods (e.g., days to weeks). The stability in solution depends on the solvent, pH, and concentration.

Practical Tip: Aliquot the reconstituted peptide into smaller volumes to avoid repeated freeze-thaw cycles. Use high-quality solvents and buffers for reconstitution and storage.

Key Takeaways

• PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist with potential research applications in sexual dysfunction and melanocortin receptor biology.
• Its mechanism of action involves binding to MC4R in the central nervous system, modulating neuronal pathways related to sexual arousal and desire.
• Key quality markers to assess include peptide purity (?95%), sequence identity (confirmed by MS), peptide content, water content (5-10%), and counterion content.
• Common impurities include deletion peptides, truncated peptides, and modified peptides.
• Proper storage at -20°C or -80°C with desiccation and light protection is crucial for maintaining stability. Avoid repeated freeze-thaw cycles.
• Request comprehensive quality data from suppliers, including RP-HPLC, MS, and water content analysis.